The 36-month beta value for POAI is at 1.21. Analysts have varying views on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 as “hold,” and 0 as “sell.”
The public float for POAI is 6.52M, and currently, shorts hold a 2.02% of that float. The average trading volume for POAI on December 27, 2024 was 100.74K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
POAI) stock’s latest price update
Predictive Oncology Inc (NASDAQ: POAI) has experienced a rise in its stock price by 15.15 compared to its previous closing price of 0.75. However, the company has seen a gain of 17.67% in its stock price over the last five trading days. globenewswire.com reported 2024-11-13 that Company initiates process to explore a broad range of strategic alternatives to maximize shareholder value Company initiates process to explore a broad range of strategic alternatives to maximize shareholder value
POAI’s Market Performance
Predictive Oncology Inc (POAI) has experienced a 17.67% rise in stock performance for the past week, with a 13.88% rise in the past month, and a 13.38% rise in the past quarter. The volatility ratio for the week is 9.99%, and the volatility levels for the past 30 days are at 8.95% for POAI. The simple moving average for the past 20 days is 11.41% for POAI’s stock, with a -26.99% simple moving average for the past 200 days.
Analysts’ Opinion of POAI
Many brokerage firms have already submitted their reports for POAI stocks, with H.C. Wainwright repeating the rating for POAI by listing it as a “Buy.” The predicted price for POAI in the upcoming period, according to H.C. Wainwright is $3 based on the research report published on August 19, 2024 of the current year 2024.
POAI Trading at 15.96% from the 50-Day Moving Average
After a stumble in the market that brought POAI to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -77.15% of loss for the given period.
Volatility was left at 8.95%, however, over the last 30 days, the volatility rate increased by 9.99%, as shares surge +7.38% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +56.15% upper at present.
During the last 5 trading sessions, POAI rose by +17.67%, which changed the moving average for the period of 200-days by -69.86% in comparison to the 20-day moving average, which settled at $0.7710. In addition, Predictive Oncology Inc saw -73.89% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for POAI
Current profitability levels for the company are sitting at:
- -9.58 for the present operating margin
- 0.08 for the gross margin
The net margin for Predictive Oncology Inc stands at -10.13. The total capital return value is set at -3.59. Equity return is now at value -193.25, with -102.54 for asset returns.
Based on Predictive Oncology Inc (POAI), the company’s capital structure generated 0.09 points at debt to capital in total, while cash flow to debt ratio is standing at -61.27.
Currently, EBITDA for the company is -13.18 million with net debt to EBITDA at 0.05. When we switch over and look at the enterprise to sales, we see a ratio of 3.66. The receivables turnover for the company is 2.97for trailing twelve months and the total asset turnover is 0.18. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.20.
Conclusion
In conclusion, Predictive Oncology Inc (POAI) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
